Money matters: how cost-effectiveness studies are done.
Sarah L
SL
Zielinski
D003131:Combined Modality Therapy / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*; D019057:Quality-Adjusted Life Years; D014481:United States